FDA Ends Semaglutide Shortage Listing Amid Ongoing Legal Challenges
Semaglutide injections officially removed from the FDA drug shortage list, though localized availability issues persist. Tirzepatide shortage status remains contested by the Outsourcing Facilities Association.